GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » Capex-to-Operating-Income

Novonesis AS (Novonesis AS) Capex-to-Operating-Income : 0.57 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Novonesis AS's Capital Expenditure for the three months ended in Dec. 2023 was $-88.37 Mil. Its Operating Income for the three months ended in Dec. 2023 was $156.41 Mil.

Hence, Novonesis AS's Capex-to-Operating-Income for the three months ended in Dec. 2023 was 0.57.


Novonesis AS Capex-to-Operating-Income Historical Data

The historical data trend for Novonesis AS's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Capex-to-Operating-Income Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.26 0.32 0.65 0.46

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.05 0.36 0.54 0.40 0.57

Competitive Comparison of Novonesis AS's Capex-to-Operating-Income

For the Specialty Chemicals subindustry, Novonesis AS's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis AS's Capex-to-Operating-Income Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis AS's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Novonesis AS's Capex-to-Operating-Income falls into.



Novonesis AS Capex-to-Operating-Income Calculation

Novonesis AS's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-300.813) / 653.128
=0.46

Novonesis AS's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-88.371) / 156.405
=0.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novonesis AS  (OTCPK:NVZMY) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Novonesis AS Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (Novonesis AS) Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso 11-06-2019

Not Just Yogurt Anymore

By PRNewswire 10-26-2023

Novozymes A/S's Dividend Analysis

By GuruFocus Research 10-19-2023